The tumor suppressor gene 14-3-3 σ is commonly methylated in normal and malignant lymphoid cells

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 2, 2003, Pages 165-169

  Bhatia, Kishor ^a,b   Siraj, Abdul K ^a   Hussain, Azhar ^a   Bu, Rong ^a   Gutiérrez, Marina I ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KFNCCC and R   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN 14 3 3;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CHILD; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE INACTIVATION; HUMAN; HUMAN CELL; LYMPHOID CELL; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; ALLELES; CHILD; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EXONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LYMPHOCYTES; MALE; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0037320357     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Tzivion, G., and Avruch, J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem., 277: 3061-3064, 2002.
2. Subramanian, R. R., Masters, S. C., Zhang, H., and Fu, H., Functional conservation of 14-3-3 isoforms in inhibiting Bad-induced apoptosis. Exp. Cell Res., 271: 142-151, 2001.
3. Prasad, G. L., Valverius, E. M., McDuffie, E., and Cooper, H. L. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ., 3: 507-513, 1992.
4. Fu, H., Subramanian, R. R., and Masters, S. C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol., 40: 617-647, 2000.
5. van Hemert, M. J., Steensma, H. Y., and van Heusden, G. P. 14-3-3 proteins: key regulators of cell division, signaling and apoptosis. Bioassays, 23: 936-940, 2001.
6. Singal, R., and Ginder, D. G. DNA methylation. Blood, 93: 4059-4070, 1999.
7. Gasco, M., Sullivan, A., Repellin, C., Brooks, L., Farrell, P. J., Tidy, J. A., Dunne, B., Gusterson, B., Evans, D. J., and Crook, T. Coincident inactivation of 14-3-3 Sigma and pl6(INK4a) is an early event in vulval squamous neoplasia. Oncogene, 21: 1876-1881, 2002.
8. Kang, G. H., Lee, S., Kim, W. H., Lee, H. W., Kim, J. C., Rhyu, M. G., and Ro, J. Y. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am. J. Pathol., 160: 787-794, 2002.
9. Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A., Marks, J., and Sukumar, S. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene, 20: 3348-3353, 2001.
10. Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., Satoh, T., Toyota, J., Satoh, M., Endo, T., and Imai, K. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Oncogene, 19: 5298-5302, 2000.
11. Suzuki, H., Itoh, F., Toyota, M., Kikuchi, T., Kakiuchi, H., and Imai, K. Inactivation of the 14-3-3 sigma gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res., 60: 4353-4357, 2000.
12. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J.- R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., and Sukumar, S. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA, 97: 6049-6054, 2000.
13. Rountree, M. R., Bachman, K. E., Herman, J. G., and Baylin, S. B. DNA methylation, chromatin inheritance and cancer. Oncogene, 20: 3156-3165, 2001.
14. Razin, A., and Shemer, R. DNA methylation in early development. Hum. Mol. Genet., 4: 1751-1755, 1995.
15. Park, C. W., and Chung, J. H. Age-dependent changes of p57(Kip2) and p21 (Cipl/Wafl) expression in skeletal muscle and lung of mice. Biochem. Biophys. Acta, 1520: 163-168, 2001.
16. Reik, W., Dean, W., and Walter, J. Epigenetic reprogramming in mammalian development. Science (Wash. DC), 293: 1089-1093. 2001.
17. Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C. L., Duan, H., and Domann, F. E. Role for DNA methylation in the control of cell type-specific maspin expression. Nat. Genet., 31: 175-179, 2002.
18. Gutierrez, M. I., Chemey, B., Hussain, A., Mostowski, H., Tosato, G., Magrath, I., and Bhatia, K. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Res., 59: 696-703, 1999.
19. Warnecke, P. M., Stirzaker. C., Melki, J. R., Millar, D. S., Paul, C. L., and Clark, S. J. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res., 25: 4422-4426, 1997.
20. Kawano, S., Miller, C. W., Gombart, A. F., Bartram, C. R., Matsuo, Y., Asou, H., Sakashita, A., Said, J., Tatsumi, E., and Koeffler, H. P. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood, 94: 1113-1120, 1999.
21. Katzenellenbogen, R. A., Baylin, S. B., and Herman, J. G. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 93: 4347-4353, 1999.
22. Gutierrez, M. I., Bhatia, K., Cherney, B., Capello, D., Gaidano, G., and Magrath, I. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. Ann. Oncol., 8: 987-994, 1997.
23. Harrison, J., Stirzaker, C., and Clark, S. J. Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. Anal. Biochem., 264: 129-132, 1998.
24. Cameron, E. E., Baylin, S. B., and Herman, J. G. pl5(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood, 94: 2445-2451, 1999.
25. Aggerholm, A., Guldberg, P., Hokland, M., and Hokland, P. Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res., 59: 436-441, 1999.
26. Sakashita, K., Koike, K., Kinoshita, T., Shiohara, M., Kamijo, T., Taniguchi, S., and Kubota, T. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J. Clin. Investig., 108: 1195-1204, 2001.
27. Walsh, C. P., and Bestor, T. H. Cytosine methylation and mammalian development. Genes Dev., 13: 26-34, 1999.
28. Kuromitsu, J., Kataoka, H., Yamashita, H., Muramatsu, M., Furuichi, Y., Sekine, T., and Hayashizaki, Y. Reproducible alterations of DNA methylation at a specific population of CpG islands during blast formation of peripheral blood lymphocytes. DNA Res., 2: 263-267, 1995.
29. Schwab, J., and Illges, H. Regulation of CD21 expression by DNA methylation and histone deacetylation. Int. Immunol., 13: 705-710, 2001.
30. Razin, S. V., Ioudinkova, E. S., and Scherrer, K. Extensive methylation of a part of the CpG island located 3.0-4.5 kbp upstream to the chicken alpha-globin gene cluster may contribute to silencing the globin genes in non-erythroid cells. J. Mol. Biol., 299: 845-852, 2000.